FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma. Issue 2 (10th November 2021)

Record Type:
Journal Article
Title:
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma. Issue 2 (10th November 2021)
Main Title:
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma
Authors:
Adib, Elio
El‐Zarif, Talal
Jain, Rohit K.
Skelton, William P.
Freeman, Dory
Curran, Catherine
Akl, Elie W.
Nassar, Amin H.
Ravi, Praful
Mantia, Charlene
Kwiatkowski, David J.
Choueiri, Toni K.
Sonpavde, Guru P.
Abstract:
Is Part Of:
BJUI Compass. Volume 3:Issue 2(2022)
Journal:
BJUI Compass
Issue:
Volume 3:Issue 2(2022)
Issue Display:
Volume 3, Issue 2 (2022)
Year:
2022
Volume:
3
Issue:
2
Issue Sort Value:
2022-0003-0002-0000
Page Start:
169
Page End:
172
Publication Date:
2021-11-10
Subjects:
biomarkers -- bladder cancer -- enfortumab vedotin -- genomics -- targeted therapy
Genitourinary organs -- Diseases -- Periodicals
Genitourinary organs -- Surgery -- Periodicals
Urology -- Periodicals
616.6
Journal URLs:
http://onlinelibrary.wiley.com/ ↗
https://bjui-journals.onlinelibrary.wiley.com/journal/26884526 ↗
DOI:
10.1002/bco2.125 ↗
Languages:
English
ISSNs:
2688-4526
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21111.xml